Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
OptimizeRx Corporation (NASDAQ: OPRX) is a digital health technology company that operates at the intersection of healthcare information technology, life sciences marketing, and clinical workflow optimization. The company provides cloud-based platforms that enable pharmaceutical manufacturers and healthcare organizations to deliver financial, clinical, and brand-related information to healthcare providers directly within electronic health record (EHR) systems. Its core value proposition centers on improving patient access to therapies while supporting provider decision-making at the point of care.
The company’s primary revenue drivers are derived from subscription and usage-based fees paid by pharmaceutical and life sciences companies for digital engagement, patient affordability messaging, and provider-facing communications. OptimizeRx primarily serves pharmaceutical manufacturers, biotechnology companies, and healthcare providers, with a strategic advantage rooted in its deep integration across leading U.S. EHR platforms. Founded in 2006, OptimizeRx evolved from a medication adherence and e-prescribing support tool into a broader healthcare engagement platform through organic development and targeted acquisitions.
Business Operations
OptimizeRx generates revenue primarily through its Life Sciences Engagement and Healthcare Provider Solutions business activities, which are delivered via proprietary cloud-based software platforms embedded within EHR workflows. These solutions allow life sciences companies to communicate savings offers, therapy alternatives, adherence programs, and educational content to clinicians in real time. The company operates predominantly on a software-as-a-service (SaaS) model, with recurring revenue tied to campaign volume, program duration, and provider reach.
Operations are primarily U.S.-focused, reflecting the structure of the domestic healthcare system and EHR market, though the company maintains a limited international footprint. OptimizeRx controls proprietary technologies that integrate with major EHR vendors and maintains key subsidiaries including OptimizeRx, Inc., CareSpeak Communications, and RMDY Health, which expand its capabilities in omnichannel patient engagement and provider messaging. The company does not manufacture hardware and relies on strategic integration partnerships rather than joint ventures.
Strategic Position & Investments
OptimizeRx’s strategic direction emphasizes growth in omnichannel healthcare engagement, deeper EHR integration, and expanded use of data-driven personalization for life sciences customers. The company has pursued growth through acquisitions, most notably CareSpeak Communications (acquired in 2020) to enhance provider messaging capabilities, and RMDY Health (acquired in 2021) to add patient engagement and adherence solutions.
Ongoing investments focus on enhancing analytics, real-world data insights, and workflow-native communications that support commercialization efforts for specialty and chronic therapies. OptimizeRx positions itself as a neutral platform within the healthcare ecosystem, aiming to align the interests of providers, patients, and pharmaceutical manufacturers while navigating increasing regulatory scrutiny and demand for measurable return on investment in digital health marketing.
Geographic Footprint
OptimizeRx is headquartered in the United States, with its principal executive offices located in Massachusetts. The company’s operational presence and customer base are concentrated primarily in North America, reflecting its reliance on U.S. EHR infrastructure and pharmaceutical commercialization models.
While international operations are limited, OptimizeRx’s technology platform is designed to be scalable, and the company has indicated interest in selective international expansion where healthcare digitization and regulatory frameworks support EHR-based engagement. As of the most recent public disclosures, international revenue contribution remains immaterial relative to U.S. operations.
Leadership & Governance
OptimizeRx is led by an executive team with experience across healthcare technology, life sciences commercialization, and enterprise software. The leadership emphasizes disciplined growth, operational efficiency, and expanding the company’s role as a trusted intermediary within clinical workflows.
Key executives include:
- William J. Febbo – Chief Executive Officer
- Robert J. Hall – Chief Financial Officer
- David Harrell – Chief Operating Officer
- Amy G. Brown – Chief Legal Officer and Corporate Secretary
- David Kretchmer – Chief Commercial Officer
The company operates under a board-governed structure consistent with U.S. public company standards, with a stated focus on shareholder value creation, compliance, and long-term strategic alignment between healthcare stakeholders.